What is Heron Neutron Medical Corp.'s (7799.TW) StockRank?

MoatMap's StockRank for Heron Neutron Medical Corp. (7799.TW) is 13/100, with a Strong Sell signal. This is a composite score combining Quality (43), Value (23), and Momentum (29) factor ranks across MoatMap's 20,000+ stock universe.

Does Heron Neutron Medical Corp. have an economic moat?

Heron Neutron Medical Corp. (7799.TW) has a Quality factor score of 43/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the financial characteristics of a moated business.

Is Heron Neutron Medical Corp. a buy, hold, or sell?

MoatMap's current signal for Heron Neutron Medical Corp. (7799.TW) is Strong Sell, based on a StockRank of 13/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.

What sector is Heron Neutron Medical Corp. in?

Heron Neutron Medical Corp. (7799.TW) operates in the Healthcare sector, specifically the Medical Devices industry (Taiwan).

Company Deep Dive

Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.

Request Deep Dive(50 Feathers)

7799.TW

STRONG SELLREMOVE

Heron Neutron Medical Corp. · Healthcare · Taiwan · $1.9B · Avg Vol: $7M/d

StockRank

P/E (TTM)

—

ROE

-7.2%

D/E

0.0x

Dividend %

—

Director Trades · 180d

None in 180d →

Buybacks · 180d

None in 180d →

AI CONVICTION THESIS

Heron Neutron Medical is a medical device company focused on niche cancer therapy equipment, lacking the recurring revenue, scale, or CDMO characteristics required.

COMPANY DESCRIPTION

Heron Neutron Medical Corp. develops advanced Boron Neutron Capture Therapy (BNCT) systems for cancer treatment. The company designs and manufactures accelerator-based BNCT equipment, offering a highly targeted, non-invasive radiation therapy solution for deep-seated tumors. It operates as a high-tech medical device pioneer, leveraging proprietary nuclear physics and medical imaging technologies to secure a unique position in oncology.

FINANCIAL SUMMARY (USD)

Year	2022	2023	2024	2025	CAGR
Revenue	0	7,520	0	0.3M	558.1%
EPS	-0.04	-0.04	-0.06	-0.10	—
Shares	140.7M	140.7M	140.7M	157.5M	+12.0%
Debt	0.5M	0.4M	0.3M	0.2M	-25.2%
Equity	18.7M	25.5M	46.5M	363.0M	169.0%
Op CF	-2.0M	-1.7M	-8.2M	-15.3M	—
Inv CF	-3.6M	-1.8M	-4.7M	-276.8M	—
Fin CF	5.6M	10.6M	28.4M	343.5M	—

PRICE (1Y)+22.0%

SMA 50SMA 200

$12.42

RSI (14)

58.9

SCORE BREAKDOWN

Quality

ROIC

-4.2%39.8

ROE

-7.2%37.3

GP/Assets

-0.2%9.0

Op. Margin

-3067.4%4.3

FCF/Assets

-3.9%37.7

Piotroski

438.9

Int. Cover

-50.0x6.0

D/E Ratio

0.02x82.8

Current Ratio

305.62x100.0

Value

P/E (TTM)

—N/A

EV/EBITDA

-87.2x25.0

P/FCF

—N/A

P/B

4.9x26.6

P/S

4289.9x1.4

Div Yield

—N/A

Momentum

52W High %

—N/A

RS 6M

-101%8.7

SMA 50/200

0.70x4.7

EPS Rev 4W

+0.5%74.4

EPS Rev 12W

—N/A

EPS Improve

—94.8

Q Growth

—N/A

FUNDAMENTALS

Market Cap

$1.9B

P/E (Forward)

36.8x

Gross Margin

-202.3%

SECTOR PEERS

Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of 7799.TW are excluded.

Ticker	Company	Mkt Cap	StockRank	Signal
7799.TW	Heron Neutron Medical Corp.(you)	$1.9B	13	STRONG SELL
6796.TW	Medimaging Integrated Solution Inc.	$75M	12	STRONG SELL
6934.TW	HCMED INNOVATIONS CO LTD	$78M	4	STRONG SELL
6861.TW	InnoCare Optoelectronics Corporation	$497M	72	BUY
4129.TWO	United Orthopedic Corporation	$275M	64	HOLD
4736.TW	TaiDoc Technology Corporation	$368M	91	STRONG BUY
4155.TW	OK Biotech Co., Ltd.	$67M	66	BUY
1795.TW	Lotus Pharmaceutical Co., Ltd.	$1.6B	29	SELL
4743.TWO	Oneness Biotech Co., Ltd.	$726M	11	STRONG SELL
6918.TW	A Plus Biotechnology Co., Ltd.	$80M	74	BUY

Peer medians: ROE 3.6% · P/E 16.2x · Gross margin 42.1%

Heron Neutron Medical Corp. (7799.TW) — Stock Score Summary

Heron Neutron Medical Corp. (7799.TW) has a MoatMap StockRank of 13/100 based on Quality (43/100), Value (23/100), and Momentum (29/100) factor scores. The current signal is STRONG SELL. Heron Neutron Medical is a medical device company focused on niche cancer therapy equipment, lacking the recurring revenue, scale, or CDMO characteristics required.

Key Financial Metrics

Price	$12.42
Market Cap	$1.9B
P/E (Forward)	36.77
Price/Book	4.87
Return on Equity	-7.2%
Return on Invested Capital	-4.2%
Debt/Equity	2.03
Gross Margin	-202.3%
Operating Margin	-3067.4%
Revenue Growth	1159.8%
Free Cash Flow	$-456K

Heron Neutron Medical Corp. operates in the Medical Devices industry, part of the Healthcare sector (Taiwan).

Frequently Asked Questions

What is Heron Neutron Medical Corp.’s (7799.TW) StockRank?: MoatMap’s StockRank for Heron Neutron Medical Corp. (7799.TW) is 13/100, with a Strong Sell signal. It is a composite of Quality (43), Value (23), and Momentum (29) factor ranks across MoatMap’s 20,000+ stock universe.
Does Heron Neutron Medical Corp. have an economic moat?: Heron Neutron Medical Corp. (7799.TW) has a Quality factor score of 43/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Heron Neutron Medical Corp. a buy, hold, or sell?: MoatMap’s current signal for Heron Neutron Medical Corp. (7799.TW) is Strong Sell, based on a StockRank of 13/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Heron Neutron Medical Corp. in?: Heron Neutron Medical Corp. (7799.TW) operates in the Healthcare sector, specifically the Medical Devices industry (Taiwan).